Headache

Article	Citations
Erratum	97
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	89
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	73
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	53
Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment	51
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	43
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	39
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	37
Migraine screening in English and Spanish	32
Migraine and peripheral pain models show differential alterations in neuronal complexity	31
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report	30
Post‐traumatic headache: An unmet medical need	29
A retrospective cohort study of clinical factors, visit patterns, and demographic factors associated with use of remote communications in patients with headache	29
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	28
A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine	27
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine	27
Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions	27
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	26
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	25
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	25
Patient preference for early onset of efficacy of preventive migraine treatments	24
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	24
Sex and gender: Opportunities to expand research and understanding within headache medicine	24
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study	24
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	24

The teaching of headache medicine in France: A questionnaire‐based study	23
Clinical characteristics and perfusion‐computed tomography alterations in a series of patients with migraine with aura attended as stroke code	23
Prevalence of primary stabbing headache: A meta‐analysis	23
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	23
A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine	23
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa	22
Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study	22
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study	21
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐bl	21
Neuromodulation for primary headache disorders: Advantages and challenges	21
Crystal‐clear days and unclear days in migraine: A population‐based study	21
Patient headache questionnaires can improve headache diagnosis and treatment in children	21
Headache and acute cerebrovascular disease: How do we differentiate primary and secondary headache disorders in the emergency setting?	20
Dietary sodium and headache are linked by cerebrospinal fluid sodium concentration to sodium‐specific appetite, tolerance, and perceptive reward	20
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis	20
Index	20
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine	20
The elephant in the room: How the underfunding of headache research stunts the field	19
	19
Issue Information	19
Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System	19
Issue Information	19
Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial	19
Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings	18
Validation of a Portuguese version of the four‐item Migraine Interictal Burden Scale	18
OnabotulinumtoxinA as a promising treatment for primary trochlear headache: A retrospective case series	18
A large language model–based generative natural language processing framework fine‐tuned on clinical notes accurately extracts headache frequency from electronic health records	17
Recurrent painful ophthalmoplegic neuropathy with headache and oculomotor palsy 18 years apart	17
Dystonia phenomenology and treatment response in migraine	17
The 2024 Headache editorial board Conflict of Interest Declarations	17
Protracted headache after COVID‐19: A case series of 31 patients from a tertiary headache center	17
Changes in cognitive appraisal in a randomized controlled trial of mindfulness‐based cognitive therapy for patients with migraine	17
Prevalence, characteristics, and factors associated with caffeine‐withdrawal headache during the first day of Ramadan	16
Socioeconomic and geographic inequalities in headache disability in Brazil: The 2019 National Health Survey	16
Alcohol as a trigger of migraine attacks in people with migraine. Results from a large prospective cohort study in English‐speaking countries	16
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data	16
Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis	16
Different dosage regimens of erenumab for the treatment of migraine: A systematic review and meta‐analysis of the efficacy and safety of randomized controlled trials	15
Challenges in the management of new daily persistent headache at a tertiary headache center—A retrospective real‐world evidence study	15
Prediction of individual trigeminal pain sensitivity from gray matter structure within the sensorimotor network	15
	15
Emergency department utilization among patients who receive outpatient specialty care for headache: A retrospective cohort study analysis	15
Red flags in headache care	15
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials	15
Essential components of care in a multidisciplinary headache center: Perspectives from headache neurology specialists	14
Issue Information	14
The 2025 Headache Editorial Board conflict of interest declarations	14
Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE‐1 and EVOLVE‐2	14
Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data	14
Plain Language Summary Publication: Investigating the causal and genetic relationship between migraine and Parkinson’s disease	14

Afterimage duration differs for migraine with or without aura	14
Burden of migraine in Brazil: A cross‐sectional real‐world study	14
Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial	14
Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists	14
The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence	14
Issue Information	14
Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in	14
Effect of wildfire smoke on primary headache disorders remains unclear	13
Intracranial hypotension as a contributor to isolated cortical vein thrombosis	13
Essential but often overlooked reporting elements for Headache manuscripts	13
Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache	13
Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials	13
A man with tongue pain: A case study	13
American Headache Society 64th Annual Scientific Meeting June 9–12, 2022 Denver, Colorado	13
Headache in transgender men using gender‐affirming hormone therapy: A case–control study	13
Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study	12
Beyond aura: Understanding migraine as a cycling pan‐sensory threshold disease	12
Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral	12
Characterization of trigeminal C‐fiber reactivity through capsaicin‐induced release of calcitonin gene‐related peptide	12
Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache	12
Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype	12
Decision‐making impairment under ambiguity but not under risk may underlie medication overuse in patients with chronic migraine	12
Plasma calcitonin gene–related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion	12
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice	12
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial	12
Secondary nummular headache: Are they more common than we thought?	12
Arachnoid granulations in idiopathic intracranial hypertension: Do they have an influence?	12
Are psychological interventions efficacious for adults with migraine? A systematic review and meta‐analysis	12
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial	12
Basic Science Prize Award 2024	12
Digital headache self‐management interventions for patients with a primary headache disorder: A systematic review of randomized controlled trials	11
	11
The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure	11
Mechanisms of change in posttraumatic headache–related disability: A mediation model	11
Exploring the impact of acute SARS‐CoV‐2 infection on headache pattern in patients with migraine: A novel Bayesian analysis	11
Cluster Analysis of Migraine‐associated Symptoms (CAMS) in youth: A retrospective cross‐sectional multicenter study	11
The link between reversible cerebral vasoconstriction syndrome and transient global amnesia	10
A randomized trial of ketorolac and metoclopramide for migraine in the emergency department	10
Magnetoencephalography studies in migraine and headache disorders: A systematic review	10
Plain Language Summary Publication: Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open‐label, clinical trial	10
Visual hypersensitivity in patients treated with anti‐calcitonin gene–related peptide (receptor) monoclonal antibodies	10
Migraine and infertility, merging concepts in women's reproductive health: A narrative review	10
Migraine epidemiology in collegiate student‐athletes: Findings from the Concussion Assessment, Research, and Education (CARE) Consortium	10
Blink reflex: A practical test to evaluate the trigeminal nerve injury following percutaneous balloon compression for the treatment of trigeminal neuralgia	10
Issue Information	10
Validity of self‐reported migraine in adolescents and children	10
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle	10
Time to reconsider the association between migraine and white matter hyperintensities?	10
Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine	9
The impact of updates in headache quality measures on adherence to best practices in a neurology resident clinic: A quality improvement study	9
Beyond movement: Headache in patients with functional movement disorders	9
The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties	9
	9
	9
Causal associations between genetically predicted placental weight and migraine	9
Response to: Disagreement with Categorization of Clinical Trials included in Treadwell et al. Systematic Review and Meta‐Analysis	9
Development and validation of a novel patient‐reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary	9
Identifying and predicting headache trajectories among those with acute post‐traumatic headache	9
The importance of patient and family perspectives of clinical decisions in pediatric headache	9
Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program	9
Issue Information	9
Migraine in the context of chronic primary pain, chronic overlapping pain disorders, and functional somatic disorders: A narrative review	9
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment	9
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapists	9
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study	9
Neuropathic changes in corneal nerve endings—A potential objective biomarker for migraine frequency and response to treatment	8
Trainee highlights	8
	8
Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study	8
Long‐term evolution of white and gray matter structural properties in migraine	8
A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth	8
Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial	8
	8
Preliminary exploration of a multidimensional sleep health composite in adolescent females with frequent migraine	8
Issue Information	8
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine	8
Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies	8
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis	8
Patient headache questionnaires can improve headache diagnosis and treatment in children	8
Letter to the Editor regarding “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”	8

Celebrating Headache's 2023 graduating class of Assistant Editors	8
The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model	8
Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi‐center study	8
Correction to “A causative role for remote dural puncture and resultant arachnoid bleb in new daily persistent headache: A case report”	8
Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study	8
Heavy metal and trace element alterations in patients during a migraine attack	8
Counting the cost: How migraine shapes lives and economies	8
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (	8
Symptomatic visual snow in acute ischemic stroke: A case series	8
	8
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine	7
New insight into the neural mechanisms of migraine in adolescents: Relationships with sleep	7
Issue Information	7
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition	7
Good News? Bad News? Idiopathic intracranial hypertension and migraine	7
Insight of a headache medicine provider in Indian Health Service: A personal and professional observation	7
Welcoming Headache's 2024 incoming class of Assistant Editors	7
A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 1	7
Plain Language Summary Publication: Regulation of headache response and transcriptomic network by the trigeminal ganglion clock	7
Machine learning models and classification algorithms in the diagnosis of vestibular migraine: A systematic review and meta‐analysis	7
A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study	7
Headache basic science prize	7
Investigating the effects of weather on headache occurrence using a smartphone application and artificial intelligence: A retrospective observational cross‐sectional study	7
Efficacy of an educational website on headaches in schoolchildren: A cluster‐randomized controlled trial	7
American Headache Society 67th Annual Scientific Meeting June 19–22, 2025 Minneapolis, Minnesota	7
Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study	7
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States	7
Indomethacin‐responsive idiopathic red ear syndrome: A pediatric case	7
Different characteristics of cortical spreading depression in the sleep and wake states	7
Virtual issue: Recent advances in pediatric headache: Bridging the data gap	7
Baseline factors associated with post‐stenting intracranial pressure in patients with idiopathic intracranial hypertension with venous sinus stenosis	7
Intranasal treatment of cluster headache: A response	7
Pain medication beliefs in individuals with headache	6
	6
Learning headache triggers through experience: A laboratory study	6
	6
Twenty twenty … two: Headache and COVID‐19	6
AHS 2021 consensus on integrating new migraine therapies into clinical practice: Isn’t our goal choice of best therapy regardless of cost?	6
Sex influences the progression of cephalic mechanical and light hypersensitivities in a mouse model of chronic migraine	6
Potential drug interaction between calcitonin gene‐related peptide antagonists and neonatal Fc receptor inhibitors	6
Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies	6
Efficacy of galcanezumab in proline‐rich transmembrane protein 2 (PRRT2)‐associated familial hemiplegic migraine: A case series	6
Multi‐region local field potential signatures and brain coherence alternations in response to nitroglycerin‐induced migraine attacks	6
Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomi	6
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review	6
Ramadan fasting in smokers with primary headache disorders: Impact of nicotine dependence on headache frequency and severity	6
Asking the right questions: The value of headache specialty care	6
Advancing our commitment to our peer reviewers	6
Epidemiology, investigation, management, and outcome of headache in emergency departments (HEAD study)—A multinational observational study	6
A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache	6
Alterations in the structure and function of the brain in adolescents with new daily persistent headache: A pilot MRI study	6
A rare case of lupus cerebritis presenting as ictal epileptic headache: A case report	6
Issue Information	6
Real world evidence of changes in CGRP monoclonal antibody and onabotulinumtoxinA prescription practices at the start of the COVID‐19 pandemic: An observational, retro	6
Lacosamide for refractory trigeminal neuralgia and other facial pain—Case report	6
Headache neuroimaging: A survey of current practice, barriers, and facilitators to optimal use	6
Sustained response of galcanezumab in migraine prevention: Patient‐level data from a post hoc analysis in patients with episodic or chronic migraine	6
The impact of a digital platform on migraine patient‐centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish	6
Trainee highlights	6
Headache launches the publication of plain language summaries	6
Changes in migraine characteristics over 30 days of Ramadan fasting: A prospective study	6
The complex relationship between alcohol and migraine	6
Altered brain functional connectivity in patients with tension‐type headache	6
Circannual worsening in cluster headache correlates with daylight change	5
Erratum	5
Issue Information	5
Bridging the gap between preclinical scientists, clinical researchers, and clinicians: From animal research to clinical practice	5
A qualitative evidence synthesis of patient perspectives on migraine treatment features and outcomes	5
Changes in gamma‐aminobutyric acid and glutamate/glutamine levels in the right thalamus of patients with episodic and chronic migraine: A proton magnetic resonance spectroscopy study	5
Development and initial validation of the Kiswahili version of the Migraine Disability Assessment (MIDAS‐K) questionnaire	5
Headache Assistant Editors 2021–2022	5
Daith piercing: Revisited from the perspective of auricular acupuncture systems. A narrative review	5
Safety of remote electrical neuromodulation for acute migraine treatment in pregnant women: A retrospective controlled survey‐study	5
Author response to comments on our article “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”	5
The impact of headache intensity on speech in participants with migraine and acute post‐traumatic headache	5
American Headache Society white paper on treatment of post‐traumatic headache from concussion in youth	5
Headache associated with COVID‐19: Epidemiology, characteristics, pathophysiology, and management	5
Development of the Migraine‐Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study	5
Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment	5
Management and outcomes of persistent headache after accidental dural puncture in the obstetric population: A 9‐year prospective audit	5
	5
	5
Spontaneous involution of a large pineal cyst: Case report and narrative review	5
Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study	5
	5
Changes in opioid prescribing in veterans with headache during the COVID‐19 pandemic: A regression discontinuity in time analysis	5
Adverse childhood experiences and onset of migraine in Canadian adolescents: A cohort study	5
Cardiovascular risk and triptan usage among patients with migraine	5
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review	5
Patterns of clinical and imaging presentations in patients with spontaneous intracranial hypotension due to spinal cerebrospinal fluid venous fistula: A single‐center retrospective cross‐sectional stu	5
Trainee highlights	5
Persistence of headache and its relation to other major sequelae following traumatic brain injury at 2–8 years after deployment‐related traumatic brain injury in veterans of Afghanistan and Iraq wars	5
Are there differences between patients with unifocal nummular headache and those who progress to bifocal nummular headache? A retrospective observational study	5
Mechanisms for mindfulness in migraine: Does catastrophizing matter?	5
Safety, tolerability, and pharmacokinetics of single and multiple ascending doses of zavegepant nasal spray in healthy adults from two phase 1 randomized, placebo‐controlled trials	5